SC
ASND icon

Sculptor Capital’s Ascendis Pharma A/S ASND Stock Holding History

Sculptor Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-149,900
Closed -$1.99M – 296
2016
Q2 		$1.99M Buy
+149,900
New +$2.31M 0.01% 264

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sculptor Capital's ASND Position: Q3 2016 in Review

Sculptor Capital sold out of Ascendis Pharma A/S (ASND) in Q3 2016, closing a stake of 149,900 shares — an estimated $1.99M sold.

Sculptor Capital first reported a position in ASND in Q2 2016 and held it in 1 quarter. The position peaked at $1.99M in Q2 2016. 22 funds tracked by Wall St. Rank hold ASND as of Q3 2016.

  • Sculptor Capital reported no remaining Ascendis Pharma A/S position as of Q3 2016 after selling out during the quarter.
  • Sculptor Capital sold 149,900 Ascendis Pharma A/S shares in Q3 2016, an estimated $1.99M.
  • Sculptor Capital first reported a position in Ascendis Pharma A/S in Q2 2016 and held it in 1 quarter.
  • Sculptor Capital's Ascendis Pharma A/S position peaked at $1.99M in Q2 2016.
  • 22 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2016.

Based on Sculptor Capital's 13F filing for Q3 2016, filed 10 Nov 2016.